Cargando…

Measuring Frailty Using Patient-Reported Outcomes (PRO) Data: A Feasibility Study in Patients with Multiple Myeloma

PURPOSE: The objective of this retrospective study was to determine the feasibility of measuring frailty using patient responses to relevant EORTC QLQ-C30 items as proxy criteria for the Fried Frailty Phenotype, in a cohort of patients with Relapsed/Refractory Multiple Myeloma (RRMM). METHODS: Data...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murugappan, Meena N., King-Kallimanis, Bellinda L., Bhatnagar, Vishal, Kanapuru, Bindu, Farley, Joel F., Seifert, Randall D., Stenehjem, David D., Chen, Ting-Yu, Horodniceanu, Erica G., Kluetz, Paul G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025057/ https://www.ncbi.nlm.nih.gov/pubmed/36935467 http://dx.doi.org/10.1007/s11136-023-03390-5

Ejemplares similares

Review of patient-reported outcomes in multiple myeloma registrational trials: highlighting areas for improvement
por: Fernandes, Laura L., et al.
Publicado: (2021)

Analysis of racial and ethnic disparities in multiple myeloma US FDA drug approval trials
por: Kanapuru, Bindu, et al.
Publicado: (2022)

Use of patient-reported outcomes (PRO) data to complement exposure–response analysis in early clinical cancer drug development
por: Xia, Huiming, et al.
Publicado: (2023)

High rifaximin out-of-pocket costs are associated with decreased treatment retention among patients with hepatic encephalopathy
por: Aby, Elizabeth S., et al.
Publicado: (2023)

Using structural equation modeling to detect response shift in performance and health-related quality of life scores of multiple sclerosis patients
por: King-Kallimanis, Bellinda L., et al.
Publicado: (2011)

Erratum to: Using structural equation modeling to detect response shift in performance and health-related quality of life scores of multiple sclerosis patients
por: King-Kallimanis, Bellinda L., et al.
Publicado: (2011)

Patient-reported treatment-related symptom burden for patients with advanced melanoma in Canada
por: Cheung, Winson Y., et al.
Publicado: (2018)

Testing the Assumption of Measurement Invariance in the SAMHSA Mental Health and Alcohol Abuse Stigma Assessment in Older Adults
por: King-Kallimanis, Bellinda L., et al.
Publicado: (2011)

Development of the Brief Ageing Perceptions Questionnaire (B-APQ): a confirmatory factor analysis approach to item reduction
por: Sexton, Eithne, et al.
Publicado: (2014)

Humanistic burden of disease for patients with advanced melanoma in Canada
por: Cheung, Winson Y., et al.
Publicado: (2018)

Patient Report on the Impact of Coronavirus Disease 2019 and Living With Lung Cancer
por: Chihuri, Tendai M., et al.
Publicado: (2023)

Negative Perceptions of Aging and Decline in Walking Speed: A Self-Fulfilling Prophecy
por: Robertson, Deirdre A., et al.
Publicado: (2015)

Falls, non-accidental falls and syncope in community-dwelling adults aged 50 years and older: Implications for cardiovascular assessment
por: Bhangu, Jaspreet, et al.
Publicado: (2017)

Extreme body mass index and survival in newly diagnosed multiple myeloma patients
por: Shah, Urvi A., et al.
Publicado: (2023)

Panobinostat for the treatment of multiple myeloma: the evidence to date
por: Bailey, Hanna, et al.
Publicado: (2015)

Initial Steps in Creating a Patient-Centric Addendum to Clinical Trial Informed Consent Forms
por: King-Kallimanis, Bellinda L., et al.
Publicado: (2023)

Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy
por: Horodniceanu, Erica G., et al.
Publicado: (2017)

Assessing measurement invariance of a health-related quality-of-life questionnaire in radiotherapy patients
por: King-Kallimanis, Bellinda L., et al.
Publicado: (2011)

Innovative Partnership between a Rural Mental Health Center and Community Pharmacy: Integration of a Mental Health Pharmacist
por: Ng, ShuYing, et al.
Publicado: (2019)

N‐terminal fragment of the type‐B natriuretic peptide (NT‐proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma
por: Milani, Paolo, et al.
Publicado: (2016)

P896: DEVELOPMENT AND VALIDATION OF A FRAILTY PREDICTION MODEL MORE SUITABLE FOR MULTIPLE MYELOMA IN CHINESE PATIENTS: THE TM FRAILTY SCORE.
por: Chen, Y., et al.
Publicado: (2022)

SPIRIT-PRO Extension explanation and elaboration: guidelines for inclusion of patient-reported outcomes in protocols of clinical trials
por: Calvert, Melanie, et al.
Publicado: (2021)

Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data
por: Maignan, Kathleen, et al.
Publicado: (2022)

Geriatric Patients with Hip Fracture: Frailty and Other Risk Factors Affecting the Outcome
por: Vasu, Bindu K., et al.
Publicado: (2018)

Geriatric assessments and frailty scores in multiple myeloma patients: a needed tool for individualized treatment?
por: Möller, Mandy-Deborah, et al.
Publicado: (2021)

Social frailty predicts worse outcomes in patients with multiple myeloma: A novelty in an old approach
por: Terao, Toshiki, et al.
Publicado: (2020)

A qualitative study to understand the experience of somatostatin analog treatments from the perspective of patients with neuroendocrine tumors
por: Seo, Caroline, et al.
Publicado: (2022)

Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients
por: Djebbari, Faouzi, et al.
Publicado: (2022)

The Effects of Second Primary Malignancies and Frailty on Overall Survival and Mortality in Geriatric Turkish Patients with Multiple Myeloma
por: Ipek, Yildiz, et al.
Publicado: (2023)

BMI1 regulates multiple myeloma-associated macrophage’s pro-myeloma functions
por: Zhang, Danfeng, et al.
Publicado: (2021)

Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score
por: D’Agostino, Mattia, et al.
Publicado: (2021)

Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age
por: Engelhardt, Monika, et al.
Publicado: (2020)

Development of a new clinical index to easily assess frailty of elderly patients with multiple myeloma in Asian population
por: Lee, Ho Sup, et al.
Publicado: (2021)

Development and validation of a chemotherapy tolerance prediction model for Chinese multiple myeloma patients: The TM frailty score
por: Chen, Yadong, et al.
Publicado: (2023)

Dysphagia in Frail Patients Is Not Frailty Dysphagia
por: Smithard, David G.
Publicado: (2018)

Non‐lethal proteasome inhibition activates pro‐tumorigenic pathways in multiple myeloma cells
por: Skorda, Aikaterini, et al.
Publicado: (2019)

Patient‐Friendly Language to Facilitate Treatment Choice for Patients with Cancer
por: Kim, Janice, et al.
Publicado: (2019)

Pro: Venoarterial ECMO Should Be Considered in Patients With COVID-19
por: Bhatia, Meena, et al.
Publicado: (2021)

A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001)
por: Agarwal, Anshul, et al.
Publicado: (2022)

Interaction effects of multimorbidity and frailty on adverse health outcomes in elderly hospitalised patients
por: Lujic, Sanja, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o9v6qb4ft3edno2uqqku0fr9cp